GNH USA

Europe — EMA

Merdaten

GNH USA supplies Merdaten (Mirtazapine), a NaSSA antidepressant for major depressive disorder, offering reliable quality and regulatory compliance.

Mirtazapine

Request sourcing

1
Pack/s

What is Mirtazapine?

Mirtazapine, the active ingredient in Merdaten, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as a tablet for oral use. It is indicated for the treatment of major depressive disorder in adult patients, helping to improve mood and functional outcomes.

GNH USA supplies Merdaten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for mental‑health medication programs.

What is Mirtazapine used for?

Merdaten (mirtazapine) is used in the management of depressive disorders, acting on serotonergic and noradrenergic pathways.

- Major depressive disorder: alleviates depressive symptoms and improves overall mood and daily functioning.

What are the side effects of Mirtazapine?

Mirtazapine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Sedation or excessive drowsiness: may affect daily activities. - Increased appetite and weight gain: often reported during early treatment. - Dry mouth: can cause discomfort and dental issues. - Constipation: may require dietary adjustments.

Serious or Rare Side Effects: - Agranulocytosis or neutropenia: severe reduction in white blood cells. - Severe hypersensitivity reactions: including rash, swelling, or anaphylaxis. - Serotonin syndrome: risk when combined with other serotonergic agents. - Suicidal ideation: worsening depression may increase risk. - Significant hypotension: especially with rapid dose changes.

What precautions apply to Mirtazapine?

Before initiating therapy with Merdaten, clinicians should consider several safety measures.

- Monitor mood changes: watch for worsening depression or suicidal thoughts. - Assess hepatic function: dose adjustment may be needed in liver impairment. - Avoid abrupt discontinuation: taper gradually to reduce withdrawal symptoms. - Caution with CNS depressants: increased sedation when combined with alcohol or benzodiazepines. - Adjust dose in elderly: start low and monitor for excessive sedation. - Store at room temperature: keep in the original container, protect from moisture and light.

What does Mirtazapine interact with?

Mirtazapine can interact with other medicines, affecting safety and efficacy.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Other serotonergic agents (SSRIs, SNRIs, tramadol): may precipitate serotonin toxicity. - CNS depressants (benzodiazepines, alcohol): enhanced sedation and respiratory depression. - Anticholinergic drugs: increased anticholinergic burden. - Potent CYP2D6 inhibitors: may raise mirtazapine plasma levels.

Moderate Interactions (Monitor Closely): - CYP2D6 substrates (e.g., metoprolol): possible altered metabolism. - Antihypertensive agents: additive hypotensive effect. - Antidiabetic medications: monitor blood glucose changes. - Warfarin: potential effect on INR, require monitoring. - Oral contraceptives: may reduce efficacy, advise alternative contraception.

Frequently asked questions

What is Merdaten used for?+
Merdaten contains the active ingredient mirtazapine and is prescribed for the treatment of major depressive disorder in adult patients. It helps to alleviate depressive symptoms, improve mood, and support functional recovery as part of a comprehensive mental‑health care plan.
How does mirtazapine work?+
Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine and serotonin. It also antagonizes postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic activity while reducing stimulation of receptors associated with anxiety and nausea, thereby producing an antidepressant effect.
What is the usual dose of Merdaten?+
The dosage of Merdaten is individualized by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. The prescriber determines the appropriate starting dose, titration schedule, and maintenance dose, following local prescribing guidelines and patient‑specific factors.
Is Merdaten safe during pregnancy or breastfeeding?+
The safety of mirtazapine in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Clinicians should discuss possible risks and alternatives with the patient before initiating therapy.
How do I order Merdaten from GNH USA?+
To order Merdaten, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Merdaten compare with other antidepressants?+
Merdaten (mirtazapine) belongs to the NaSSA class, differing from SSRIs and SNRIs by its dual antagonism of α2‑adrenergic and specific serotonin receptors. This mechanism often results in pronounced sedative and appetite‑stimulating effects, which can be advantageous for patients with insomnia or weight loss, but may be less suitable for those concerned about weight gain.
What are the storage and handling requirements for Merdaten?+
Merdaten tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments to maintain stability and potency.
How is Merdaten administered?+
Merdaten is taken orally, usually once daily in the evening due to its sedative properties. The tablet should be swallowed whole with water and not chewed or crushed, unless otherwise directed by a healthcare professional.
What are the most serious risks associated with Merdaten?+
Serious risks include the potential for agranulocytosis or neutropenia, severe hypersensitivity reactions, serotonin syndrome when combined with other serotonergic agents, and worsening depression that may increase suicidal thoughts. Patients should be monitored closely for any signs of these conditions, especially during treatment initiation and dose changes.
Who should not use Merdaten?+
Merdaten is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients, those currently taking monoamine oxidase inhibitors (MAOIs), and individuals with severe hepatic impairment where dose adjustment is not feasible. Caution is also advised for patients with a history of bipolar disorder, as it may precipitate manic episodes.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mirtazapine
Route
Oral Use
Manufacturer
Rafarm Sa.
Origin
EU

Related products